Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells

Cell Growth and Differentiation

Volumn 7, Issue 12, 1996, Pages 1713-1721

  Buckley, Arthur R ^a   Left, Matthew A ^a   Buckley, Donna J ^a   Magnuson, Nancy S ^b   De Jong, Gary ^c   Gout, Peter W ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; MESSENGER RNA; MYC PROTEIN; PROLACTIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMEDIATE EARLY GENE; LYMPHOMA CELL; MITOGENESIS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; T CELL LYMPHOMA;

ANIMALS; BLOTTING, NORTHERN; BUTYRIC ACID; BUTYRIC ACIDS; CELL DIVISION; FLOW CYTOMETRY; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HISTONE DEACETYLASES; LYMPHOMA, T-CELL; PROLACTIN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS C-PIM-1; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0029807613     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gout, P. W., Beer, C. T., and Noble, R. L. Prolactin-stimulaled growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res., 40: 2433-2436, 1980.
2. Fleming, W. H., Pettigrew, N. M., Matusik, R. J., and Freisen, H. G. Thymic origin of the prolactin-dependent Nb2 lymphoma cell line. Cancer Res., 42: 3138-3141, 1982.
3. Cox, J. H., Lamb, J. R., Bal, V., Butcher, G. W., Howard, J. C., Owen, M. J., and Ivanyi, J. The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone. J. Immunol., 66: 83-89, 1989.
4. Rui, H., Kirken, R. A., and Farrar, W. L. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem., 269: 5364-5367, 1994.
5. fyn is associated with PRL receptor and is activated by PRL stimulation of T-lymphocytes. Mol. Endocrinol., 8: 674-681, 1994.
6. ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells. Cell Growth & Differ., 6: 1235-1244, 1995.
7. Stevens, A. M., and Yu-Lee, L-Y. The transcription factor interferon regulatory factor-1 is expressed during both early G1 and G1/S transition in the prolactin-induced lymphocyte cell cycle. Mol. Endocrinol., 6: 2236-2243, 1992.
8. Buckley, A. R., Buckley, D. J., Leff, M. A., Hoover, D. S., and Magnuson, N. S. Rapid induction of pim-1 expression by prolactin and interleukin 2 in rat Nb2 lymphoma cells. Endocrinology, 136: 5252-5259, 1995.
9. Horseman, N. D. Prolactin, proliferation, and protooncogenes. Endocrinology, 136: 5249-5251, 1995.
10. Gout, P. W. Transient requirement for prolactin as a growth initiator following treatment of autonomous Nb2 node rat lymphoma cell cultures with butyrate. Cancer Res., 47: 1751-1755, 1987.
11. Gout, P. W., Horsman, D. E., Fox, K., De Jong, G., Ma, S., and Bruchovsky, N. The rat Nb2 lymphoma: a novel model for tumor progression. Anticancer Res., 14: 2485-2492, 1994.
12. Horsman, D. E., Masui, S., and Gout, P. W. Karyotypic changes associated with loss of prolactin dependency of rat Nb2 node lymphoma cell cultures. Cancer Res., 51: 282-287, 1991.
13. Herz, F., and Halwer, M. Preferential alkaline phosphatase isoenzyme induction by sodium butyrate. Biochim. Biophys. Acta, 762: 289-294, 1983.
14. Gum, J. R., Kam, W. K., Byrd, J. C., Hicks, J. W., Sleisenger, M. H., and Kim, Y. S. Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J. Biol. Chem., 262: 1092-1097, 1987.
15. Tsao, D., Morita, A., Bella, A., Luu, P., and Kim, Y. S. Differential effects of sodium butyrata, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins on human rectal adenocarcinoma cells. Cancer Res., 42: 1052-1058, 1982.
16. Hague, A., Manning, A. M., Hanlon, K. A., Huschtscha, L. I., Hart, D., and Paraskeva, C. Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55: 498-505, 1993.
17. Health, D. P., Zirnstein, G. W., Bradley, J. F., and Rothberg, P. G. Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J. Biol. Chem., 268: 20466-20472, 1993.
18. Souleimani, A., and Asselin, C. Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett., 326: 45-50, 1993.
19. Velcich, A., and Augenlicht, L. H. Regulated expression of an intestinal mucin gene in HT29 colonic carcinoma cells. J. Biol. Chem., 268: 13956-13961, 1993.
20. Souleimani, A., and Asselin, C. Regulation of c-fos expression by sodium butyrate in the human carcinoma cell line Caco-2. Biochem. Biophys. Res. Commun., 193: 330-336, 1993.
21. Dang, J., Wang, Y., and Doe, W. F. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells. FEBS Lett., 359: 147-150, 1995.
22. Riggs, M. G., Whittaker, R. G., Neumann, J. R., and Ingram, V. M. n-Butyrate causes histone modification in HeLa and Friend erythroleukemia cells. Nature (Lond.), 268: 462-464, 1977.
23. Candido, E. P., Reeves, R., and Davie, J. R. Sodium butyrate inhibits histone deacetylase in cultured cells. Cell, 14: 105-113, 1978.
24. Sealy, L., and Chalkley, R. The effect of sodium butyrate on histone modification. Cell, 14: 115-121, 1978.
25. Boffa, L. C., Vidali, G., Mann, R. S., and Allfrey, V. G. Suppression of histone deacetylase in vivo and in vitro by sodium butyrate. J. Biol. Chem., 253: 3364-3366, 1978.
26. Kruh, J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem., 42: 65-82, 1982.
27. Murphy, P. R., DiMattia, G. E., and Freisen, H. G. Role of calcium in prolactin-stimulated c-myc gene expression and mitogenesis in Nb2 lymphoma cells. Endocrinology, 122: 2476-2485, 1988.
28. Buckley, A. R., Buckley, D. J., Gout, P. W., Liang, H-Q., Rao, Y-P., and Blake, M. J. Inhibition by genistein of prolactin-induced Nb2 lymphoma cell mitogenesis. Mol. Cell. Endocrinol., 98: 17-25, 1993.
29. Wingett, D., Reeves, R., and Magnuson, N. S. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J. Immunol., 147: 3653-3659, 1991.
30. Shaw, G., and Kamen, R. A. A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46: 659-667, 1986.
31. Reeves, R., Elton, T., Nissen, M., Lehn, D., Johnson, K. Posttranscriptional gene regulation and specific binding of nonhistone protein HMG-1 by the 3′-untranslated region of bovine interleukin-2 cDNA. Proc. Natl. Acad. Sci. USA, 84: 6531-6535, 1987.
32. Reeves, R., and Magnuson, N. S. Mechanisms regulating transient expression of mammalian cytokine genes and cellular oncogenes. Prog. Nucleic Acids Res. Mol. Biol., 38: 241-282, 1990.
33. Moray, T., Grzeschiczek, A., Petzold, S., and Hartman, K-U. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc. Natl. Acad. Sci. USA, 90: 10734-10738, 1993.
34. Wyllie, A. H., Rose, K. A., Morris, R. G., Steel, C. M., Foster, E., and Spandidos, D. A. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br. J. Cancer, 56: 251-259, 1987.
35. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
36. Askew, D. S., Ashmun, R. A., Simmons, B. C., and Cleveland, J. L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene, 6: 1915-1922, 1991.
37. Milner, A. E., Grand, R. J. A., Waters, C. M., and Gregory, C. D. Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene, 8: 3385-3391, 1993.
38. Hoover, D., Friedman, M., Reeves, R., and Magnuson, N. S. Recombinant human pim-1 protein exhibits serine/threonine kinase activity. J. Biol. Chem., 266: 14018-14022, 1991.
39. Friedman, M., Nissen, M. S., Hoover, D. S., Reeves, R., and Magnuson, N. S. Characterization of the proto-oncogene pim-1: kinase activity and substrate recognition sequence. Arch. Biochem. Biophys., 298: 594-601, 1992.
40. Van Lohuizen, M., Verbeck, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiwicz, T., and Berns, A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56: 673-682, 1989.
41. Breurer, M., Wientjens, E., Verbeck, S., Slebos, R., and Berns, A. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Cancer Res., 51: 958-963, 1991.
42. Witorsch, R. J., Day, E. B., LaVoie, H. A., Hashemi, N., and Taylor, J. K. Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells. Proc. Soc. Exp. Biol. Med., 203: 454-460, 1993.
43. Breitman, T. R., and Tryi, H. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Cancer Res., 50: 6268-6273, 1990.
44. Mollinedo, F., Gajate, C., Tugores, A., Flores, I., and Naranjo, J. R. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes. Biochem. J., 294: 137-144, 1993.
45. Rabizadeh, E., Shaklai, M., Nudelman, A., Eisenbach, L., and Rephaeli, A. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. FEBS Lett., 328: 225-229, 1993.
46. Filippovich, I., Sorokina, N., Khanna, K. K., and Lavin, M. F. Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA. Biochem. Biophys. Res. Commun., 198: 257-265, 1994.
47. Heruth, D. P., Zirnstein, G. W., Bradley, J. F., and Rothberg, P. G. Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J. Biol. Chem., 268: 20466-20472, 1993.
48. Souleimani, A., and Asselin, C. Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett., 326: 45-50, 1993.
49. Gupta, S., Alpini, G., Vemura, R. P., Hurston, E., and Shafritz, D. A. Butyrate synchronization of hepatocytes: modulation of cycling and cell cycle regulated gene expression. Growth Factors, 10: 171-180, 1994.
50. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
51. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
52. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.